From the weekly letter · 26 October 2026

Why cover this story this week?

How low must a disease-linked protein go?

Lowering the prion protein PrP can slow prion disease in animals, but preventing symptoms has proved harder. A new preprint reports that a potent siRNA, delivered into the cerebrospinal fluid, reduced PrP to 12% residual in whole brain hemispheres of mice. Early, repeated treatment kept infected animals free of symptoms through 500 days post-inoculation, suppressed prion replication by 100-fold and minimized neuropathological changes. Treatment begun after symptoms appeared also substantially extended survival.

The depth of the reduction appears important: prion strains that respond differently to more modest lowering were both effectively addressed by deep knockdown. The researchers suggest that differences between these strains may involve neurotoxicity rather than replication speed. A separate siRNA targeting human PRNP durably lowered PrP in humanized mice and cynomolgus macaques, providing a bridge toward translation—not evidence of disease prevention in people. Beyond prion research, the study illustrates how the degree of target suppression can determine whether an intervention merely slows a process or keeps its consequences at bay.

Editorial context written by AI from abstracts, not independent scientific validation. The kit and its verified quotes rely on the source paper, not on this letter.

Read the full letter →

Talk about a paper in public without overstating it: yours, one you are asked to comment on, or one you write about as a journalist.

  • Your paper: a draft release for your press office, the questions journalists will ask with what the paper lets you answer, the likely misreadings, a lay summary and a short thread.
  • Asked to comment: what the paper shows and does not, its strengths and weaknesses with their passages, and what would settle its main claim.
  • Writing about it as a journalist: reporting angles, the wording to check before publication, and the questions to ask the authors.
  • For everyone: findings with their passages checked word for word, the novelty set against the closest earlier papers, a hype check, figures with their credit, and researchers for an outside view who have not signed with the authors.

Discover Premium+ See an example kit